Clinical Trials Browser

Phase 2 × Completed × Infectious Mononucleosis × Clear all

NCT00430534 2007-02-02

Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).

Phase 2 Completed

Infections, Infectious Mononucleosis, Epstein-Barr Virus Infections